The Effect of Nitric Oxide with Minimal Stimulation on Patients with Polycystic Ovarian Syndrome by Kobre Amir Ajam et al.
Int  J Women’s Health Reproduction Sci Vol. 2, No. 3, Spring 2014        ISSN 2330-4456 
The Effect of Nitric Oxide with Minimal Stimulation on 
Patients with Polycystic Ovarian Syndrome 
 Kobre Amir Ajam 1 , Laya Farzadi 2*, Mohammad Nouri 1, M M Sadagheani 1 
Abstract 
Objectives: Infertility is one of the most prevalent problems 
among  young  couples  especially  in  women  with  Polycystic 
Ovary  Syndrome.  In  women,  PCO is  associated  with  lack  of 
ovulation, abdominal obesity and insulin resistance. The aim of 
this  study  is  to  investigate  the  effect  of  nitric  oxide  with 
minimal stimulation in the treatment of infertility in women 
with PCOS. 
Materials and Methods: In a randomized single blind clinical 
trial (RCT), 120 women who had polycystic ovarian syndrome 
(PCOS), were with PCOS who were eligible to be studied were 
divided into two groups; study group and a control group (60 
patients in each group) and the effects of Nitric Oxide with 
minimal  stimulation  on  the  treatment  of  infertility  were 
investigated in the patients who were being treated with IUI. 
Results: The mean age of the patients, who were 21 to 35 years 
old, was 28.3±4.2 years. In the study group, 43 cases (71.7%) 
and in the control group, 52 cases (86.7%) had ovulation. The 
difference  between  these  two  groups  was  statistically 
significant  (p=0.03).  The  successful  pregnancy  rate  was  10 
cases (16.6%) in the study group and 8cases in the control 
group (13.3%), however this difference was not statistically 
significant (p=0.18). The difference between the two groups 
regarding mature follicles was not significant either (p=0.27), 
but the difference regarding the endometrial thickness on the 
gonadotropin administration day was statistically significant 
(p=0.02). 
Conclusion: According to the results and since there was not a 
significant difference between the two groups regarding the 
pregnancy rate, it can be concluded that employing nitric oxide 
tablets in addition to the common treatment, does not affect 
pregnancy rate in women with PCOS. 
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Introduction:  
Polycystic Ovarian Syndrome (PCOS) is one 
of  the  most  common  endocrine  disorders 
that affect about 5-10% of the women at the 
fertility  age.  The  increase  in  the  level  of 
androgen is evident in 60-80% of the women 
with  PCOS.  Hyperandrogenism  is  an 
independent risk factor which can result in 
high  blood  pressure  and  an  increased 
possibility  of  cardiovascular  diseases  in 
women with Polycystic Syndrome. Women 
with PCO and lack of ovulation, suffer from 
abdominal  obesity  and  insulin  resistance 
which leads to the increase in the possibility 
of  the  diabetes  type  2  and  cardiovascular 
diseases.  Hyperandrogenism  along  with 
hirsutism and acne causes neuropsychiatric 
symptoms in these patients. 
Polycystic  Syndrome  is  the  most  common 
cause of oligomenorrhea and hirsutism in a 
way  that  87%  of  the  women  with 
oligomenorrhea and 92% of the women with 
hirsutism  show  polycystic  ovarian 
symptoms (3, 4). One of the other important 
disorders  caused  by  polycystic  ovarian 
syndrome  is  infertility.  According  to  the 
previous research, the reason for the lack of 
ovulation in 83% of the infertile couples is 
polycystic  ovarian  syndrome  and  among 
56%  of  the  couples  who  had  inexplicable 
fertility, 44% of them were reported to have 
polycystic ovary with ovulation periods (5). 
It  seems  that  hyperandrogenism  (acne, 
hirsutism,  and  alopecia)  and  menstrual 
disturbances  (oligomenorrhea)  are  shown 
in  70.3  and  66.2  %  of  the  patients 
respectively. It is possible to diagnose the 
disease  based  on  the  sonography  results, 
one or two clinical symptoms of the disease, 
or  endocrine  disorders  in  the  form  of 
increase in the serum concentration of LH 
and  testosterone  (6).Nitric  oxide  is  a  free 
radical gas whose effect does not last long 
and is made up of L- Arginine and is believed 
to be the main intervention in the most of the 
natural  functions  of  the  cardiovascular 
organs,  reproductive  organs,  immune 
system  and  digestion  (7).  Based  on  the 
results of several studies, ovaries are able to 
synthesize  nitric  oxide  and  possibly  this 
substance  has  a  role  in  ovary  steroid 
production, ovulation, and the destruction of 
the corpus Luteum (8). It seems that nitric 
oxide does not affect ovaries only when they 
are under natural conditions. Local effects of 
nitric  oxide  in  polycystic  ovary  syndrome 
and  with  inexplicable  reasons  have  been 
have been proved (9).There are studies that 
emphasize  the  effect  of  nitric  oxide  on 
steroid  production  in  ovaries.  During 
animal’s  sexual  cycle,  several  changes  in 
hormonal  activities  and  in  ovaries  take 
place.  Nitric  oxide  activity  in  the  steroid 
production  of  the  corpus  Luteum  is 
important  (7).  Under  the  cellular  culture 
conditions, nitric oxide takes the aromatase 
enzyme activity under control and decreases 
estradiol production (10). 
Since  a  lot  of  different  studies  have  been 
carried out on this topic all over the world, 
and since it has never been investigated in 
the patients in our area, the present study 
investigated the effects of nitric oxide with 
minimal  stimulation  in  the  treatment  of 
infertility in patients with polycystic ovarian 
syndrome. 
General purpose of the study: 
the  general  purpose  of  this  study  was  to 
investigate  the  effect  of  nitric  oxide  with 
minimal  stimulation  in  the  treatment  of 
infertility in patients with polycystic ovarian 
syndrome. 
Specific Purposes of the Study: 
The specific purposes of the study are: 
1.  Determine  the effect of  the  nitric  oxide 
with minimal stimulation on the number of 
the  mature  follicles  on  the  day  of  the 
administration of HCG. 
2.  Determine  the effect of  the  nitric  oxide 
with  minimal  stimulation  on  the 
endometrial  thickness  on  the  day  of  the 
administration of HCG. 
3.  Determine  the effect of  the  nitric  oxide 
with  minimal  stimulation  on  the  rate  of 
ovulation  by  administering  trans  vaginal 
sonography on the day of IUI. 
4.  Determine  the effect of  the  nitric  oxide 
with minimal stimulation on the pregnancy 
rate. 
Practical Purpose of the Study: 
If  this  treatment  is  proved  to  be  effective 
compared to the other common treatments, 
it can also be used to treat the patients with 
polycystic ovarian syndrome. K Amir Ajam et al 
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Study Hypotheses: 
1. Nitric oxide with minimal stimulation has 
no significant effects on the number of the 
mature follicles. 
2. Nitric oxide with minimal stimulation has 
no  significant  effects  on  the  endometrial 
thickness. 
3. Nitric oxide with minimal stimulation has 
no significant effects on the rate of ovulation; 
4. Nitric oxide with minimal stimulation has 
no significant effects on the pregnancy rate. 
Literature Review: 
Infertility  and  the  assisted  reproductive 
techniques in women suffering from PCOS: 
Infertility  is  defined  as  an  inability  to 
conceive  after  a  year  of  regular  sexual 
intercourse  without  contraception. 
Nowadays,  10-15%  of  the  couples  are 
infertile. Thus, it can be assumed that there 
are more than 80 million people in the world 
who are infertile. In Iran, it is estimated that 
of the population of 72 million people (18 
million couples), more than 2 million people 
are  faced  with  the  infertility  problems. 
World  Health  Organization  (WHO)  has 
declared infertility as an important problem 
in  the  reproductive  health  with  many 
physical-mental and social dimensions (18). 
There  are  two  main  methods  to  treat 
infertility; intrauterine insemination of the 
sperm (IUI) along with controlled ovarian 
hyper  stimulation  (COH),  and  assisted 
reproductive techniques (ART) (19).By the 
prescription of ovulation-stimulating drugs, 
ovaries  are  stimulated  to  grow  follicles 
containing oocytes. Follicle maturation time 
is determined by the several sonographies of 
the  ovaries  and  the  measurement  of  the 
serum estradiol which start 8 days after the 
beginning of the treatment (20). 
 (22).There are studies which emphasize the 
role of nitric oxide in steroid production in 
the ovaries. Several changes happen in ovary 
and hormonal activities of animals in their 
sexual cycle. The role of nitric oxide role is 
important  in  steroid  production  of  the 
corpus  Luteum  (7).Nitric  oxide  takes  the 
enzyme  system  of  the  aromatase  under 
control  and  reduces  the  production  of 
estradiol  (10).In  a  study  entitled 
‘investigating the level of NO in the patients 
with  and  without  PCOS’  by  Erdogan  et  al 
(2008)  at  the  University  of  Ege  in  Izmir, 
Turkey, the findings showed the level of NO 
did  not  differ  significantly  between  the 
patients  with  PCOS  and the  control  group 
(23).Findings of a similar study in Brazil by 
Nacul et al (2007) indicated that in patients 
with  PCOS,  the  level  of  insulin  has  a 
significant  negative  correlation  with  the 
production of NO (24).In a research study in 
Turkey by Turkcuoglu et al (2010), the level 
of  NO  in  the  patients  with  PCOS  was 
investigated.  The  results  showed  that  the 
level  of  NO  has  a  significant  negative 
correlation with the level of fasting insulin 
and also the level on NO is related to the high 
level  of  fasting  insulin  in  these  patients 
(25).In some studies, it has been reported 
that  NO  is  important  to  support  the 
decidualization  processes  and  has  a 
protective role in implantation. In this study, 
it has been shown that Clomiphene citrate 
can  have  destructive  effects  on  the  blood 
circulation  of  the  ovarian  artery  and  that 
accompanying with NO in the ovarian blood 
circulation  and  endometrial  vascular  and 
admitting  it  can  improve  pregnancy  rate 
(26). 
Another study showed that oral L-arginine 
supplementation  as  an  NO  donor,  has 
improved the ovarian response, endometrial 
admission,  and  pregnancy  rate  in  the 
patients with a very poor ovarian response, 
who  go  through  assisted  reproductive 
techniques (27). 
Material & Methods: 
Study design: 
In  a  randomized  single  blind  clinical  trial 
(RCT),  120  women  who  had  polycystic 
ovarian syndrome (PCOS), were divided into 
two groups of study and control (60 patients 
in each group) and were investigated. The 
subjects were aged between 20 and 35, had 
one or two open Oviducts in HSG and had 
been  infertile  for  over  three  years.  The 
results of the sperm analysis of the subjects’ 
spouses were appropriate for IUI.  
Setting and the Duration of the Study: 
The study was carried out in the infertility 
ward  of  the  Alzahra  Teaching  Hospital 
dependent  on  the  Tabriz  University  of 
Medical Sciences. 
The study took place in 12 months, starting 
in January, 2012 and ending in March, 2013. 
During this time, the researchers collected  
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raw data, examined patients, and analyzed 
data. 
Ethical Considerations: 
In  this  study  no  other  extra  or  unethical 
intervention  was  applied  for  the  patients 
being studied.  
All  information  about  the  patients  is 
confidential. All of the procedures employed 
including  hysterosonography,  sperm 
analysis, clomiphene administration, and IUI 
assisted  reproductive  technique  are  based 
on valid references and studies, among the 
conventional  methods  of  diagnostic  and 
therapeutic  that  are  applied  by  different 
physicians for the infertile women.  
In  this  study,  there  was  no  ethical 
prohibition except for the general principles 
of the application of the medicines and the 
study  is  based  on  existing  references. 
However,  before  the  study,  all  subjects 
signed  a  consent  form.  It  should  also  be 
mentioned that the design of this study has 
been approved by the ethics committee of 
the  Tabriz  University  of  Medical  Sciences. 
Moreover, the study has been registered in 
IRCT web-site (NO. N1 2013011512146) as 
a clinical trial study. 
Procedures: 
All women (120) who had polycystic ovarian 
syndrome  (PCOS),  were  aged  between  20 
and 35, had one or two open Fallopian tubes 
in  HSG,  had  been  infertile  for  over  three 
years and the results of the sperm analysis of 
their spouses were appropriate for IUI, were 
investigated  in  two  groups  of  study  and 
treatment in12 months after the study was 
approved.  Sampling  of  these  patients  was 
random and the subjects were divided into 
two groups employing Rand List software. 
To determine the body of the sample, the 
results of a similar study were used. In this 
study, the ovulation rate was average of 45% 
which  was  statistically  significant. 
Considering α = 0.05, power of 80% and the 
difference of 15% in the ovulation rate of 
180 patients was estimated and 60 patients 
were included in each group (120 in total). 
Polycystic ovaries were diagnosed based on 
(American  Society  of  Reproduction 
Medicine)  ASRM,  (European  Society  of 
Human Reproductive and Embryo) ESHRE 
and based on the presence of the two of the 
following criteria: 
1. Oligo-ovulation or an-ovulation 
2.  Hyperandrogenism  (clinical  or 
biochemical) 
3. Polycystic ovaries, morphology of PCO is 
defined base on the presence of 12 or more 
follicles with the thickness of 2 to 9 mm in 
ach ovary or the growth of the ovary body to 
more than 10 cm². 
The patients in both groups were treated by 
the  daily  administration  of  50mg  of 
clomiphene which started on the 3rd -5th 
day of the menstrual cycle accompanied with 
exogenous  gonadotropins.  In  the    study 
group, in addition to the above medication, 
20 mg nitric oxide tablets (ISMN) produced 
by  Iran  medicine  company  were  also 
administered  through  the  vagina  which 
started on the 3rd -5th day of the menstrual 
cycle  and  ended  on  the  diagnosis  of 
ovulation and pregnancy. 
Trans-vaginal sonography was administered 
every other day from day 12 to day 18 of the 
menstrual cycle to observe mature follicles 
(equal to or more than 18mm), and diagnose 
ovulation and the endometrial thickness and 
were recorded on the last day. If a minimum 
of  one  18  mm  follicle  was  observed, 
intramuscular  injection  of  5000  HCG  was 
administered and IUI was carried out after 
34  hours.  On  the  day  of  IUI  vaginal 
sonography  was  re-administered  to 
determine  ovulation.  Pregnancy  was 
determined  by  the  measurement  of  the 
βHCH serum in the time of missed menstrual 
period.  Treatment  was  continued  in  each 
group for three cycles. In addition to this, in 
both  groups,  age,  BMI,  FSH  rate,  LH, 
Testosterone, and the fasting insulin were 
also measured. 
Inclusion Criteria: 
1. Age range of 20 to 35. 
2.  One  or  two  open  Fallopian  tubes    in 
Hysterosonography. 
3. Appropriate sperm analysis for IUI; 
4. Infertility of over three years in women; 
5. Consent to participate in the study. 
Variables: 
- Patients’ age 
- Type of infertility 
- Type of previous treatment K Amir Ajam et al 
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- Type of medicine 
- Duration of infertility 
- Body mass index (BMI) 
- Patients’ weight 
- Patients’ height 
- Waist 
- FSH rate 
- LH rate 
- Testosterone rate 
- Insulin serum rate 
- Nitric oxide reception 
- Number of mature follicles 
- Endometrial thickness 
- Presence of ovulation 
- Medication side-effect 
- βHCG results 
All  above-mentioned  information  was 
collected using a pre-designed check list.  
Statistical analysis: 
Results have been stated in the form of mean 
±  standard  deviation,  frequency  and 
percentage.  The  statistical  software 
employed is SPSS version 16.  
To compare qualitative variables, a student 
T-test and to compare qualitative variables, 
a Chi-square test were employed. And when 
it was required, the Fisher and the McNemar 
tests were employed in both groups. Every 
test  which  had  a  P<.05  was  considered 
statistically significant.  
Results: 
In  a  randomized  single  blind  clinical  trial 
(RCT),  120  women  who  had  polycystic 
ovarian syndrome (PCOS), were divided into 
two groups of study and control (60 patients 
in  each  group) and  were  investigated.  The 
subjects were aged between 20 and 35, had 
one or two open Fallopian tubes in HSG and 
had been infertile for over three years. The 
results of the sperm analysis of the subjects’ 
spouses were appropriate for IUI. Results of 
this study are as follows.60 women (50%) 
were in the study group (group A: patients 
who  were  treated  with  exogenous 
gonadotropins + clomiphene + nitric oxide 
(ISMN)) and 60 were in the control group 
(group B: patients who were treated with 
exogenous  gonadotropins  +  clomiphene). 
All  participant  patients  were  treated  and 
examined until the end of the study. 
Age: 
The average age of all of the patients, who 
were  aged  between  20  to  35  years,  was            
28.3 ± 4.2. When groups were considered in 
isolation, the average age of the women was 
28.5 ± 4.1 (22 – 35) in the study group and 
28.1 ± 3.9 (21 – 35) in the control group. In 
this  study,  the  average  age  difference 
between the two groups was not statistically 
significant (P = .56). 
Frequency  of  the  women  in  different  age 
groups: 
Women  were  divided  into  three  groups 
based on their age: 
In group A, there were 13 women in the age 
group of under 25 (21.7%), 30 women in the 
age group of 26 – 30 (50%), and 17 women 
in the age group of 31 – 35 (28.3%). 
In group B, there were 13 women in the age 
group of under 25 (21.7%), 35 women in the 
age group of 26 – 30 (58.3%), and 12 women 
in the age group of 31 – 35 (20%). 
In  general,  the  biggest  frequency  of  the 
patients in both groups was in the age group 
of 26 – 30. The difference of the frequencies 
of the two groups of the patients was not 
significantly significant either (P = .53). 
Description of the Type of the Infertility in the 
Patients: 
The fertility among the patients of the study 
group  was  of  primary  type  in  31  cases 
(51.7%), and of secondary type in 29 cases 
(48.3%). 
In  the  control  group,  the  fertility  was  of 
primary  type  in  36  cases  (60%),  and  of 
secondary type in 24 cases (40%). According 
to the results of the statistical analysis, the 
difference of the fertility type between the 
two groups was not significant (P= .23). 
Description  of  the  Treatments  Patients 
Received before this Study: 
In the study group, 26 cases (48.3%) had 
already been treated by IUI before the study, 
while the remaining 31 cases (51.7%) had 
not received any IUI before.  
In the control group, 35 cases (58.3%) had 
already been treated by IUI before the study, 
while the remaining 25 cases (41.7%) had 
not received any IUI before. The two groups 
were  not  significantly  different  regarding 
the kind of the treatment they had received 
before the study (P= .18). 
The kind of medication patients had taken 
for  infertility  treatment  along  with  more 
details  and  the  P  values  are  illustrated  in 
table 4.1.  
K Amir Ajam et al 
Int  J Women’s Health Reproduction Sci Vol. 2, No. 3, Spring 2014                             ISSN 2330-4456 
Description of the duration of the fertility in 
the patients: 
In all patients, the duration of the infertility 
had been investigated and the one who were 
infertile for over three years were included 
in  the  study.  The  average  duration  of  the 
infertility  was  4.7  ±  2.1  years  (3  –  8)  in 
group A, and 5 ± 2.2 years (3 – 10) in group 
B. this difference between the two groups 
was not statistically significant (P = .40). 
Description of the weight indexes, waist: 
The  weight  indexes  of  the  patients  like 
weight, height, body mass index (BMI), and 
waist  were  investigated  in  this  study  and 
compared  between  the  two  groups.  The 
details of this investigation along with the P 
values are illustrated in table 4-2. 
Description of the Para-clinical indexes: 
The  para-clinical  indexes  like  FSH  and  LH 
rates, Testosterone, and the rate of serum 
insulin have been measured and compared 
between the two groups. The details of this 
investigation  along  with  the  P  values  are 
shown in table 4-3. 
Description of the Consequences of the Study: 
The consequences of the study such as the 
number of the mature follicles, the thickness 
of the endometrium on the day when HCG 
was  administered,  and  ovulation  were 
investigated in the women by trans-vaginal 
sonography  on  the  day  of  the  IUI.  The 
description  of  these  consequences,  the 
comparisons between the two groups along 
with  more  details  and  the  P  values  are 
indicated in table 4-4. 
Successful Pregnancy Cases: 
At the end of the study, a βHCG experiment 
as the final consequence of the study was 
carried  out  in  both  groups.  In  the  study 
group  with  nitric  oxide, 10  cases  (16.6%) 
and in the control group, 8 cases (13.3) had 
successful pregnancies. The difference of the 
results of the βHCG experiment (successful 
pregnancy) between the two groups was not 
statistically significant (P= .18). 
Discussion: 
As it was mentioned, nitric oxide is a free 
radical gas whose effect does not last long 
and is made up of L- Arginine and is believed 
to be the main intervention in the most of the 
natural  functions  of  the  cardiovascular 
organs,  reproductive  organs,  immune 
system  and  digestion  (7).  Based  on  the 
results of several studies, ovaries are able to 
synthesize  nitric  oxide  and  possibly  this 
substance  has  a  role  in  ovary  steroid 
production, ovulation, and the destruction of 
the corpus luteum (8).  
It  seems  that  nitric  oxide  does  not  affect 
ovaries  only  when they are  under  natural 
conditions.  Local  effects  of  nitric  oxide  in 
polycystic  ovary  syndrome  and  with 
inexplicable  reasons  have  been  have  been 
proved (9). 
There are studies that emphasize the effect 
of  nitric  oxide  on  steroid  production  of 
ovaries. During animal’s sexual cycle, several 
changes  in  hormonal  activities  and  in 
ovaries take place. Nitric oxide activity in the 
steroid  production  of  the  yellow  body  is 
important  (7).  Under  the  cellular  culture 
conditions, nitric oxide takes the aromatase 
enzyme activity under control and decreases 
estradiol production (10). 
In  this  chapter,  the  aim  is  to  discuss  the 
results of this study and compare them to the 
findings of the other studies. Therefore, we 
first point to some of the similar studies in 
this area. 
Elberry et al (2010) in a trial study in Egypt 
investigated the effects of nitric oxide on the 
improvement  of  the  successful  pregnancy 
rate in the infertile women with polycystic 
ovarian syndrome (28). 
In the above study which took place in two 
groups of clomiphene only and clomiphene 
plus nitric oxide, results indicated that in the 
study  group,  because  of  the  follicular 
maturation, the quality of the cervical mucus 
and  the  other  endometrial  characteristics 
which  resulted  from  nitric  oxide 
administration,    the  pregnancy  and  the 
ovulation  rate  also  increased  (28).  In  this 
study,  it  has  been  suggested  that  in  the 
infertile women who suffer from PCOS and 
are resistant to clomiphene, it is better that 
prior to the administration of gonadotropin 
and  ovarian  laparoscopic  surgeries,  the 
ISMN tablets be used in addition to common 
infertility treatments (28). 
In this study also like Elberry et al’s, the rate 
of the successful pregnancy was higher in 
the  study  group.  That  is,  in  patients  who 
were  treated  with  nitric  oxide,  10  cases K Amir Ajam et al 
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(16.6%) had successful pregnancies while in 
the  control  group,  8  cases  (13.3%)  had 
successful pregnancies. 
However, in contrast to Elberry et al’s study, 
the  difference in  the  successful  pregnancy 
rate  between  the  two  groups  was  not 
statistically significant (P= .18). 
Also, in contrast to Elberry et al’s study, in 
our study, the patients in both groups were 
treated  with  clomiphene  and  exogenous 
gonadotropins,  and  only  the  study  group 
received the ISMN tablets. 
In our study, the endometrial thickness as 
one of the effective factors in fertility, was 
10.3  ±  2.4  mm  in  the  study  group,  and            
9.3  ±  2.4  mm  in  the  control  group.  The 
difference between the two groups was not 
statistically significant which is in line with 
the results of Elberry et al’s study (28). 
Ramsay et  al  reported  the  increase in  the 
uterine  blood  circulation  rate  and  in  the 
Perfusion  of  the  uterine  arteries  in  the 
women  who  received  nitric  oxide.  This 
increase in turn leads to the improvement in 
the endometrial growth (29). 
Results of another similar study in Brazil by 
Nacul  et  al  (2007)  showed  that  in  the 
patients  suffering  from  PCOS,  the  level  of 
insulin has a significant negative correlation 
with NO production (24). 
In this study, like the results of Nacul et al’s 
study (24), the rate of the insulin serum in 
both  groups  of  patients  with  PCOS  was 
higher than the normal. 
In a similar study in Turkey by Turkcuoglu et 
al (2010), the level of NO in the patients with 
PCOS was investigated. The results indicated 
that the level of NO had a significant negative 
correlation with the level of fasting insulin 
and also the level of NO is related to the high 
level of insulin in these patients (25). 
Another study showed that oral L-arginine 
supplementation  as  an  NO  donor,  has 
improved the ovarian response, endometrial 
admission,  and  pregnancy  rate  in  the 
patients with a very poor ovarian response, 
who  go  through  assisted  reproductive 
techniques (27). 
Also,  in  the  study  by  Elberry  et  al,  it  was 
indicated  that  NO  can  have  Deleterious 
effects on the quality of embryo and the rate 
of  pregnancy  in  the  cycles  of  ovarian 
stimulation.  Side-effects  of  ISMN  which  is 
employed  through  the  vagina,  have  been 
reported in a few cases and cab be tolerated 
without any intervention. These side-effects 
include  nausea,  feeling  the  heat,  and 
headache (29). 
In  our  study  like  Elberry’s  (29),  no  side-
effects of ISMN were observed. 
In  our  study,  the  average  duration  of  the 
infertility was 4.7 ± 2.1 years (3-8) in the 
study group and 5 ± 2.2 years (3-10) in the 
control  group.  This  difference  was  not 
statistically  significant  between  the  two 
groups (P= .40). 
In a review of the similar studies in this area, 
we  could  not  find  any  indication  that  the 
duration of infertility can affect the response 
to  nitric  oxide  during  infertility  (28-30), 
however, in our study the two groups were 
not  statistically  different  from  each  other 
regarding this factor. 
In our study, the average age of all of the 
participants who were aged between 21 and 
35,  was  28.3  ±  4.2.    When  groups  were 
considered in isolation, the average age of 
the women was 28.5 ± 4.1 (22 – 35) in the 
study group and 28.1 ± 3.9 (21 – 35) in the 
control group. It is worth mentioning that 
this  difference  was  not  statistically 
significant. 
Like our study, in Elberry et al’s study (29), 
the difference between the two groups of the 
study  was  not  statistically  significant, 
however, in contrast to our study; there was 
a  fewer  number  of  patients  in  Elberry’s 
study.  Farzi  et  al  in  Gilan  University  of 
Medical Sciences  investigated  the  effect of 
nitroglycerin  (NTG)  injection  prior  to 
embryo transition in assisted reproductive 
techniques  (31).  Findings  showed  that 
nitroglycerin had no significant effect on the 
pregnancy rate in the study group compared 
to the placebo group. This study suggested 
that  more  research  needs  to  be  done  to 
prove the results (31).As it was mentioned, 
in  our  study  the  two  groups  were  not 
statistically  different  regarding  the  rate of 
the successful pregnancy (P=.18). This is in 
accordance with the results of the study by 
Frazi  (31),  but  not  with  the  findings  of 
Elberry et al’s study(28).It seems that there 
are  other  factors  like  maternal  factors  or 
environmental conditions are also at work 
and  can  affect  the  rate  of  ovulation  and  
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pregnancy rate. This should be investigated 
in the future studies. 
Conclusion : 
According to the results and because there 
was not a statistically significant difference 
between  the  two  groups  of  the  s tudy 
regarding the rate of successful pregnancy, it 
can be stated that the employment of nitric 
oxide  tablets  in  addition  to  the  common 
treatment  should  not  be  more  preferable 
than  the  employment  of  the  common 
treatment only in treating the women with 
polycystic ovarian syndrome. It is suggested 
that  more  multi-center  studies  be  carried 
out including more participants to clarify the 
effect of nitric oxide in assisted reproductive 
techniques.  
Suggestions for Further Research: 
In the current study, it is suggested that: 
1.A  similar  study  be  carried  out  on  the 
infertile  women  with  poly  cystic  ovarian 
syndrome  to  investigate  the  hemostatic 
status; 
2.A  similar  study  be  carried  out  on  the 
infertile  women  with  poly  cystic  ovarian 
syndrome  to  investigate  the  rate  of  the 
changes in homocysteine and fibrinogen and 
other  hemostatic  markers  in  treating 
infertility.  
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Figure 4-1. Distribution of the frequencies of the age groups in two groups. 
 
Table 4-1. Comparison of the history of previous medication between the two groups. 
 
 
  
Medication Type  Treatment group with 
ISMN 60 patients 
Control Group 
60 patients  P value 
Clomiphene  51 (%85)  55 (691.%) 
0.003 
Clomiphene + NO  9 (%15)  5 (.4%8) K Amir Ajam et al 
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 Figure ????? - Comparison of the history of previous medication between the two groups 
 
 
 
 
 
Table 4-2. The comparison of the weight indexes and waist between the two groups. 
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Comparison of the history of previous medication between the two groups
Control Group
Treatment group with ISMN
Variable  Treatment group with ISMN 
60 patients 
Control Group 
60 patients  P Value 
Weight (Kg)  74.8±10.6 
(51-93) 
71.4±11.3 
(50-89)  0.09 
Height (cm)  161.4±5.6 
(148-175) 
161.1±7 
(140-170)  0.83 
Body Mass Index 
(Kg/m2) 
28.7±3.5 
(19.5-35.1) 
27.5±4 
(19.3-33.2)  0.10 
Waist (cm)  90.9±9.7 
(66-115) 
90.3±7.6 
(66-107)  0.73  
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Table 4-3.  The comparison of the para-clinical indexes between the two groups. 
 
Table 4-4. The comparison of the consequences of the study between the two groups. 
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The comparison of the para-clinical indexes between the two groups
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Treatment group with ISMN
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follicles
The comparison of the consequences of the study between the two groups
Control Group
Treatment group with ISMN
Variable  Treatment group with ISMN 
60 patients 
Control Group 
60 patients  P Value 
FSH (mIU/L)  6.48±3.12 
(2.2-14) 
6.37±2.79 
(2.3-14)  0.85 
LH (mIU/L)  8.38±5.35 
(2.1-25) 
9.99±5.64 
(2.4-16)  0.11 
Testosterone 
(ng/mL) 
0.64±0.41 
(0.2-2.1) 
0.58±0.38 
(0.2-2.1)  0.41 
Insulin (IU/mLµ)  12.9±6.1 
(5-25.5) 
12.3±5.8 
(4.4-25)  0.63 
Variable 
Treatment group 
with ISMN 60 
patients 
Control Group 
60 patients  P Value 
Endometria 
Thickness, mm 
10.3±2.4 
(4.8-14) 
9.3±2.4 
(3.3-14)  0.02 
Presence of ovulation  43 (71.7 %)  52 (82.7 %)  0.035 
Number of the 
mature follicles 
3.33±1.79 
(1-6) 
3±1.52 
(1-6)  0.27 K Amir Ajam et al 
Int  J Women’s Health Reproduction Sci Vol. 2, No. 3, Spring 2014                             ISSN 2330-4456 
References: 
1.  Raval AD, Hunter T, Stuckey B. Statin for women with poly cystic ovary syndrome not 
actively trying to conceive. Cochrane Syst Rev. 2011; 128:65-85. 
2. Sthyapalan T, Smith KA, Coady AM. Atorvastatin therapy decrease androstendione and 
dehydroepiandrostendione sulphate concentration in patients with polycystic ovary syndrome 
randomized clinical trial. Ann Clin Biochem. 2012;  49: 80–85. 
3. Amin AF, Abd el-Aal DE, Darwish AM, Meki AR. Evaluation of the impact of laparoscopic 
ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial 
growth factor and insulin-like growth factor-1 in women with polycystic ovary syndrome. 
Fertil Steril. 2003; 79(4): 938-941. 
4. Edwards RG, Beard HK. Is the success of human IVF more a matter of genetics and 
evolution than growing blastocysts. Hum Reprod. 1999; 14(1):1-4.  
5. Engmann L, Maconochie N, Sladkevicius P, Bekir J, Campbell S, Tan SL. The outcome of 
in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian 
morphology. Hum Reprod. 1999; 14(1):167-171. 
6. Fulghesu AM, Angioni S, Frau E. (2007). Ultrasound in polycystic ovary syndrome the 
measuring  of  ovarian  stroma  and  relationship  with  circulating  androgens:  results  of  a 
multicentric study. Hum Reprod. 2007; 22(9):501-2508.  
7. Dixit VD, Parvizi N. Nitric oxide and the control of reproduction. AnimReprodSci.2001; 
65:1-16. 
8. Marinoni E, Iorio R, Villaccio B, Letizia C, Aragona C, Schimberni M, Cosmi EV. Follicular 
fluid  adrenomedullin concentrations  in  spontaneous  and stimulated cycles:  relationship  to 
ovarian function and endothelin-1 and nitric oxide. Regul Peptides. 2002; 107:125-128. 
9. Cussons AJ, Stuckey BGA, Watts  GF. Cardiovascular disease in  the polycystic ovary 
syndrome: New insights and perspectives. Atherosclerosis. 2006; 185:227-239. 
10. Weems YS, Lennon E, Uchima T, Raney A, Goto K, Ong A, Zaleski H, Weems CW. Is 
nitric oxide luteolytic or antiluteolytic. Prostaglandins Other Lipid Mediat. 2005; 8:129-138. 
11. Elberry S, Razik M. (2010). Nitric oxide donors increases pregnancy rate in clomiphene 
citrate treated polycystic ovary infertile patients. Middle East Fertility Society Journal. 2010; 
15:106-109. 
12. Ramsay B, JohnsonMR,LeoneAM. The effect of exogenous oestrogen on nitric oxide 
production  in  women:  a  placebo  controlled  crossover  study.  Br  J  Obstet  Gynecol.  1995; 
102:417-419. 
13. Nácul AP, Andrade CD, Schwarz P, de Bittencourt PI Jr, Spritzer PM. Nitric oxide and 
fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity. Eur 
J Obstet Gynecol Reprod Biol. 2007; 133(2):191-196.  
K Amir Ajam et al 
Int  J Women’s Health Reproduction Sci Vol. 2, No. 3, Spring 2014                             ISSN 2330-4456 
14. Türkçüoğlu I, Engin-Üstün Y, Turan F, Kali Z, Bay Karabulut A, Meydanli M, Kafkasli A. 
Evaluation of asymmetric dimethylarginine, nitric oxide levels and associated independent 
variables in obese and lean patients with polycystic ovarian syndrome. Gynecol Endocrinol. 
2010; 9:33-42. 
15. Honaramooz A, Cook SJ, Beard AP, Bartlewski PM, Rowling NC. (1999). Nitric oxide 
regulation of gondotropin secretion in prepubertal heifers .J Neuroendocrinol. 1999; 11:667-
676. 